glp-1 market news november 2025 Receptor Agonist to Grow at 17.5% CAGR till 2035 GLP-1 Market Trends and Global

He added that many employers expect their overall costs to rise following the potential FDA approval of oral versions of GLP-1 drugs

FLORA LICHTMAN: Yeah, I mean, and we know with food that these drugs can make you feel sick, that just the idea of eating becomes unappealing

Our aim was to quantify population-level trends in GLP-1 medicines usage, for the first time incorporating access both through the PBS and private sales. To do this, researchers used industry data to quantify total sales of GLP-1 medicines to community pharmacies, hospitals and other settings

Generics frenzy On March 20, Novo Nordisks patent on semaglutide expired in India